[Assessing resveratrol effect on ocular blood flow in experiment]

Area of Science:

• Ophthalmology
• Vascular Biology
• Pharmacology

Background:

• Retinal ischemia/reperfusion injury can lead to significant ocular damage.
• Ocular blood flow is critical for maintaining retinal health.
• Resveratrol is a polyphenol with known antioxidant and anti-inflammatory properties.

Purpose of the Study:

• To investigate the effects of resveratrol on ocular blood flow.
• To evaluate resveratrol's efficacy in a rat model of retinal ischemia/reperfusion injury.

Main Methods:

• The study involved 40 Wistar rats, with retinal ischemia/reperfusion induced by endothelin-1 injection.
• Ocular blood flow was assessed using color Doppler imaging (CDI), power Doppler (PD), and pulsed-wave spectral Doppler ultrasonography.
• Rats received resveratrol orally for two months, with some receiving it pre- and post-ischemia.

Main Results:

• Resveratrol administration reduced the severity of ischemic damage in both anterior and posterior eye segments.
• Rats treated with resveratrol showed a significant increase in peak systolic and end diastolic blood flow velocity.
• A notable decrease in the resistive index of retrobulbar arteries was observed in resveratrol-treated rats.

Conclusions:

• Two months of resveratrol use effectively improved ocular blood flow in rats.
• Resveratrol demonstrated a protective effect against retinal ischemia/reperfusion injury.
• Long-term resveratrol supplementation is a promising therapeutic strategy for ocular vascular health.